眾生藥業(002317.SZ):設立北京分公司
格隆匯 12 月 15日丨眾生藥業(002317.SZ)公佈,公司於2020年12月15日召開第七屆董事會第八次會議審議通過了《關於設立廣東眾生藥業股份有限公司北京分公司的議案》。根據《公司章程》等有關規定,此次公司設立北京分公司為屬於董事會權限範圍,無需經股東大會審議批准。
隨着公司規模的不斷擴大,結合公司自身發展需要,基於充分發揮首都優勢,第一時間瞭解行業動態,發現首都醫藥行業市場資源,強化公司的營銷業務、公共事務、研發事務等的拓展,吸引及留住一批優秀的、專業的人才,增強公司持續增長的動力。
此次設立北京分公司,不會對公司財務及經營狀況產生不利影響,不存在損害上市公司及股東利益的情形。分公司成立尚需取得工商行政管理部門的批准,按規定程序辦理工商登記手續,不存在法律、法規限制或禁止的風險。異地分公司的設立對公司的管理提出了更高要求,公司將強化管理力度,加強對其實施有效管控。公司將根據後續進展情況履行相應程序和信息披露義務,敬請投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.